Analysis of FDA Drug GMP Warning Letters for FY 2022 by GMP expert Barbara W. Unger.
Get the latest in-depth analysis of FDA Drug GMP Warning Letters for FY 2022 by GMP expert Barbara W. Unger. There was unprecedented upheaval in FDA activities, so this is a report you don’t want to miss.
✔ Combined two-year analysis of FDA Warning Letters
✔ FDA enforcement trends as indicated by this analysis
✔ How these trends compare to enforcement trends since FY2013
Offered Free by: Redica Systems
See All Resources from: Redica Systems
